rhFGF20 promotes angiogenesis and vascular repair following traumatic brain injury by regulating Wnt/β-catenin pathway

• DOI: 10.1016/j.biopha.2021.112200
• Publication Date: 2021-09-27T05:51:07Z
• Authors: Ruili Guo; Xue Wang; Yani Fang; Xiongjian Chen; Kun Chen; Wenting Huang; Jun Chen; Jian Hu; Fei Liang; Jingting Du; Confidence Dordoe; Xianxi Tian; Li Lin
• Keywords: Male; Behavior, Animal; Intracranial Pressure; Endothelial Cells; Neovascularization, Physiologic; Brain Edema; Motor Activity; Capillary Permeability; Fibroblast Growth Factors; Mice, Inbred C57BL; Disease Models, Animal; 03 medical and health sciences; 0302 clinical medicine; Blood-Brain Barrier; Cell Movement; Memory; Morris Water Maze Test; Brain Injuries, Traumatic; Animals; Humans; Angiogenesis Inducing Agents; Cells, Cultured

The pathology of cerebrovascular disorders takes an important role in traumatic brain injury (TBI) by increasing intracranial pressure. Fibroblast growth factor 20 (FGF20) is a brain-derived neurotrophic factor, that has been shown to play an important role in the survival of dopaminergic neurons and the treatment of Parkinson's disease (PD). However, little is known about the role of FGF20 in the treatment of TBI and its underlying mechanism. The purpose of this study was to evaluate the protective effect of recombinant human FGF20 (rhFGF20) on protecting cerebral blood vessels after TBI. In this study, we indicated that rhFGF20 could reduce brain edema, Evans blue penetration and upregulated the expression of blood-brain barrier (BBB)-related tight junction (TJ) proteins, exerting a protective effect on the BBB in vivo after TBI. In the TBI repair phase, rhFGF20 promoted angiogenesis, neurological and cognitive function recovery. In tumor necrosis factor-α (TNF-α)-induced human brain microvascular endothelial cells (hCMEC/D3), an in vitro BBB disruption model, rhFGF20 reversed the impairment in cell migration and tube formation induced by TNF-α. Moreover, in both the TBI mouse model and the in vitro model, rhFGF20 increased the expression of β-catenin and GSK3β, which are the two key regulators in the Wnt/β-catenin signaling pathway. In addition, the Wnt/β-catenin inhibitor IWR-1-endo significantly reversed the effects of rhFGF20. These results indicate that rhFGF20 may prevent vascular repair and angiogenesis through the Wnt/β-catenin pathway.